valerie quarmby: host cell proteins and immunogenicity
Published 7 years ago • 956 plays • Length 39:53Download video MP4
Download video MP3
Similar videos
-
51:40
valerie quarmby: assessing immunogenicity risk in biotherapeutic development
-
29:19
sophie tourdot: non-clinical immunogenicity risk assessment of therapeutic proteins
-
25:19
katie ewer: potent cellular and humoral immunogenicity of a viral vectored malaria vaccine
-
36:09
susan kirshner fda: therapeutic proteins: routes of exposure and the risk of immunogenicity
-
38:56
michael cancro: b cell selection and survival: first order considerations for immunogenicity
-
1:28:23
the role of nutrition care in mitochondrial health - aspen 2021
-
25:42
narasimha rao: fda recommendations on immunogenicity risk assessment for synthetic peptide drugs
-
43:52
biovision webinar - immunometabolism - sep 2018
-
41:23
jochem gokemeijer: immunogenicity risk assessment tool box for biologics drug development
-
37:51
bonnie rup: unwanted immunogenicity risk in biotherapeutic discovery and development
-
1:22
host cell protein data platform introduction
-
2:29
host cell protein data platform demo
-
24:38
tomer hertz and amir aharoni: protein engineering for reduced immunogenicity
-
41:31
jeremy fry: an integrated approach to managing immunogenicity risk and drug immune modulation
-
33:11
tim hickling: application of immunogenicity prediction and mitigation for biotherapeutic development
-
36:57
larry kauver: antibody repertoire monitoring: application to anti-drug antibodies
-
36:50
tim hickling: contribution of ex vivo assays to immunogenicity risk assessment
-
54:59
jeremy fry: mastering immunogenicity: tools and technologies
-
56:55
jeremy fry: tools and technologies for immunogenicity risk management
-
1:37
what is hcp (host cell protein) - interview with david chimento (rockland immunochemicals, inc.)